Volume 115
您当前的位置:首页 > 期刊文章 > 过刊浏览 > Volumes 108-119 (2025) > Volume 115
Controllable microfluidic fabrication of monodisperse PCL microspheres for soft tissue augmentation
Xing-Long Zhou a, Hao-Wen Zhu a, Han Fu a, Chang-Hai Zhou a, Da-Wei Pan a b, Yu-Chao Deng a, Wei Wang a b, Zhuang Liu a b, Rui Xie a b, Xiao-Jie Ju a b *, Liang-Yin Chu a b
a School of Chemical Engineering, Sichuan University, Chengdu, 610065, China
b National Key Laboratory of Advanced Polymer Materials, Sichuan University, Chengdu, 610065, China
10.1016/j.partic.2026.04.027
Volume 115, August 2026, Pages 78-90
Received 2 January 2026, Revised 25 March 2026, Accepted 27 April 2026, Available online 13 May 2026, Version of Record 27 May 2026.
E-mail: juxiaojie@scu.edu.cn

Highlights

• Monodisperse PCL microspheres with precise size regulation are fabricated via droplet-based microfluidics.

• PCL microspheres exhibit superior long-term stability and excellent biocompatibility.

• Monodisperse 42 μm PCL microspheres exhibit the most superior ability to stimulate collagen neogenesis.


Abstract

Polycaprolactone (PCL) microspheres are emerging as versatile biomaterials for minimally invasive soft tissue augmentation due to their tunable biodegradability and favorable biocompatibility. Nevertheless, the extent to which monodispersity governs the functional performance of PCL microspheres, particularly in modulating host tissue responses and regenerative efficacy, remains poorly understood. Herein, we propose a method to controllably prepare monodisperse oil-in-water (O/W) droplet templates using coaxial flow-focusing microfluidics, and then obtaining monodisperse PCL microspheres with programmable sizes via solvent evaporation. The droplet dimensions are inversely regulated by the outer-to-inner phase flow rate ratio, while PCL concentration in the organic phase exerts minimal influence on initial droplet size but markedly reduces the volume shrinkage during solidification, yielding microspheres that better retain their geometries. Notably, the resultant PCL microspheres can maintain structural integrity and size uniformity over two-month period under physiologically mimetic conditions. Comprehensive biocompatibility assessments reveal that PCL microspheres exhibit negligible hemolytic activity and cytotoxicity, demonstrating excellent hemocompatibility and cytocompatibility. Notably, in a rabbit soft tissue implantation model, monodisperse PCL microspheres with an average diameter of 42 μm elicit attenuated foreign body reactions and potentiate endogenous collagen deposition relative to the polydisperse microsphere control group. These results provide useful guidance for the application of PCL microspheres in soft tissue augmentation.

Graphical abstract
Keywords
Polycaprolactone; Microfluidics; Monodisperse microspheres; Collagen regeneration